MXH Biotech
MXH Biotech, officially known as MXH Biotech Co., Ltd., is a leading player in the biotechnology industry, headquartered in South Korea (KR). Founded in 2015, the company has rapidly established itself in major operational regions across Asia and beyond, focusing on innovative solutions in biopharmaceuticals and diagnostics. Specialising in the development of cutting-edge therapeutics and advanced diagnostic tools, MXH Biotech is recognised for its unique approach to enhancing patient outcomes through precision medicine. The company’s commitment to research and development has led to significant milestones, including partnerships with renowned research institutions. With a strong market position, MXH Biotech has garnered accolades for its pioneering products, which leverage state-of-the-art technology to address unmet medical needs. As a forward-thinking entity in the biotech sector, MXH Biotech continues to drive advancements that shape the future of healthcare.
DitchCarbon Score
How does MXH Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MXH Biotech's score of 20 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MXH Biotech's reported carbon emissions
MXH Biotech, headquartered in South Korea (KR), currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the absence of data may indicate a need for improved transparency in their environmental practices. As the biotechnology industry increasingly prioritises climate action, MXH Biotech's future commitments and strategies will be crucial in aligning with global sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MXH Biotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
